Joanne Wuensch

Stock Analyst at Citigroup

(4.29)
# 426
Out of 5,041 analysts
418
Total ratings
63.21%
Success rate
11.35%
Average return

Stocks Rated by Joanne Wuensch

Johnson & Johnson
Oct 15, 2025
Maintains: Buy
Price Target: $213$215
Current: $192.47
Upside: +11.71%
Tandem Diabetes Care
Oct 7, 2025
Maintains: Neutral
Price Target: $11$15
Current: $14.66
Upside: +2.32%
Sight Sciences
Oct 7, 2025
Maintains: Neutral
Price Target: $4.5$4
Current: $5.21
Upside: -23.22%
Medtronic
Oct 7, 2025
Maintains: Buy
Price Target: $101$112
Current: $94.21
Upside: +18.88%
iRhythm Technologies
Oct 7, 2025
Maintains: Buy
Price Target: $183$205
Current: $182.27
Upside: +12.47%
Integra LifeSciences Holdings
Oct 7, 2025
Maintains: Sell
Price Target: $10$12
Current: $15.88
Upside: -24.43%
Haemonetics
Oct 7, 2025
Maintains: Buy
Price Target: $78$64
Current: $51.35
Upside: +24.63%
Glaukos
Oct 7, 2025
Maintains: Buy
Price Target: $140$110
Current: $75.26
Upside: +46.16%
DexCom
Oct 7, 2025
Maintains: Buy
Price Target: $105$85
Current: $71.06
Upside: +19.62%
GE HealthCare Technologies
Oct 7, 2025
Downgrades: Neutral
Price Target: $93$83
Current: $77.26
Upside: +7.43%
Downgrades: Neutral
Price Target: $97$72
Current: $74.52
Upside: -3.38%
Maintains: Buy
Price Target: $157$155
Current: $126.34
Upside: +22.68%
Maintains: Neutral
Price Target: $320$285
Current: $253.51
Upside: +12.42%
Maintains: Neutral
Price Target: $38$47
Current: $49.44
Upside: -4.94%
Maintains: Neutral
Price Target: $34$32
Current: $22.99
Upside: +39.19%
Maintains: Neutral
Price Target: $13$15
Current: $15.78
Upside: -4.94%
Maintains: Buy
Price Target: $443$455
Current: $383.06
Upside: +18.78%
Maintains: Neutral
Price Target: $6.5$4.15
Current: $1.59
Upside: +161.01%
Maintains: Buy
Price Target: $590$650
Current: $551.30
Upside: +17.90%
Maintains: Buy
Price Target: $320$380
Current: $323.46
Upside: +17.48%
Maintains: Buy
Price Target: $84$95
Current: $76.53
Upside: +24.13%
Maintains: Buy
Price Target: $119$125
Current: $102.39
Upside: +22.08%
Upgrades: Buy
Price Target: $133$140
Current: $73.89
Upside: +89.47%
Maintains: Neutral
Price Target: $134$120
Current: $103.16
Upside: +16.32%
Upgrades: Neutral
Price Target: $220$250
Current: $186.53
Upside: +34.03%
Maintains: Neutral
Price Target: $67$69
Current: $76.26
Upside: -9.52%
Upgrades: Outperform
Price Target: $109$127
Current: $265.26
Upside: -52.12%